| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| EMBCEmbecta Corp. | 746.07M | 12.60 | 7.78 | -3.8% | 8.77% | 24.45% | ||
| SNOASonoma Pharmaceuticals, Inc. | 5.56M | 3.27 | -1.17 | 12.19% | -20.54% | -91.87% | 0.07 | |
| GELSGelteq Limited Ordinary Shares | 13.28M | 1.24 | -100% | -27.42% | -26.77% | 0.25 |
| Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Sales/Revenue | 1.11B | 1.09B | 1.17B | 1.13B | 1.12B | 1.12B | 1.08B |
| Revenue Growth % | - | -0.02% | 0.07% | -0.03% | -0.01% | 0% | -0.04% |
| Cost of Goods Sold | 323M | 322.9M | 365M | 354.6M | 370.9M | 387.9M | 403.6M |
| COGS % of Revenue | 0.29% | 0.3% | 0.31% | 0.31% | 0.33% | 0.35% | 0.37% |
| Gross Profit | 786M | 762.6M | 800M | 774.9M | 749.9M | 735.2M | 676.8M |
| Gross Margin % | 0.71% | 0.7% | 0.69% | 0.69% | 0.67% | 0.65% | 0.63% |
| Gross Profit Growth % | - | -0.03% | 0.05% | -0.03% | -0.03% | -0.02% | -0.08% |
| Operating Expenses | 284M | 276.1M | 308M | 465.3M | 528.4M | 568.4M | 434.7M |
| OpEx % of Revenue | 0.26% | 0.25% | 0.26% | 0.41% | 0.47% | 0.51% | 0.4% |
| Selling, General & Admin | 222M | 214.7M | 240M | 294.8M | 341.3M | 365.1M | 332M |
| SG&A % of Revenue | 0.2% | 0.2% | 0.21% | 0.26% | 0.3% | 0.33% | 0.31% |
| Research & Development | 62M | 61.4M | 63M | 66.9M | 85.2M | 78.8M | 37.3M |
| R&D % of Revenue | 0.06% | 0.06% | 0.05% | 0.06% | 0.08% | 0.07% | 0.03% |
| Other Operating Expenses | 0 | 0 | 5M | 103.6M | 101.9M | 124.5M | 65.4M |
| Operating Income | 502M | 486.5M | 492M | 309.6M | 221.5M | 166.8M | 242.1M |
| Operating Margin % | 0.45% | 0.45% | 0.42% | 0.27% | 0.2% | 0.15% | 0.22% |
| Operating Income Growth % | - | -0.03% | 0.01% | -0.37% | -0.28% | -0.25% | 0.45% |
| EBITDA | 538M | 524.5M | 530M | 341.3M | 254.1M | 203M | 293.2M |
| EBITDA Margin % | 0.49% | 0.48% | 0.45% | 0.3% | 0.23% | 0.18% | 0.27% |
| EBITDA Growth % | - | -0.03% | 0.01% | -0.36% | -0.26% | -0.2% | 0.44% |
| D&A (Non-Cash Add-back) | 36M | 38M | 38M | 31.7M | 32.6M | 36.2M | 51.1M |
| EBIT | 500M | 486.5M | 492M | 368.5M | 212.7M | 156.5M | 243.6M |
| Net Interest Income | 0 | 0 | 0 | -46.2M | -107M | -112.3M | -107.3M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 46.2M | 107M | 112.3M | 107.3M |
| Other Income/Expense | -2M | -700K | 2.9M | -53M | -115.8M | -122.6M | -105.8M |
| Pretax Income | 500M | 485.8M | 495M | 256.6M | 105.7M | 44.2M | 136.3M |
| Pretax Margin % | 0.45% | 0.45% | 0.42% | 0.23% | 0.09% | 0.04% | 0.13% |
| Income Tax | 68M | 58.2M | 80M | 33M | 35.3M | -34.1M | 40.9M |
| Effective Tax Rate % | 0.86% | 0.88% | 0.84% | 0.87% | 0.67% | 1.77% | 0.7% |
| Net Income | 432M | 427.6M | 414.8M | 223.6M | 70.4M | 78.3M | 95.4M |
| Net Margin % | 0.39% | 0.39% | 0.36% | 0.2% | 0.06% | 0.07% | 0.09% |
| Net Income Growth % | - | -0.01% | -0.03% | -0.46% | -0.69% | 0.11% | 0.22% |
| Net Income (Continuing) | 432M | 427.6M | 415M | 223.6M | 70.4M | 78.3M | 95.4M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 7.58 | 7.50 | 7.31 | 3.89 | 1.22 | 1.34 | 1.62 |
| EPS Growth % | - | -0.01% | -0.03% | -0.47% | -0.69% | 0.1% | 0.21% |
| EPS (Basic) | 7.58 | 7.50 | 7.31 | 3.92 | 1.23 | 1.36 | 1.64 |
| Diluted Shares Outstanding | 57M | 57M | 56.8M | 57.06M | 57.76M | 58.33M | 58.91M |
| Basic Shares Outstanding | 57M | 57M | 56.8M | 57.06M | 57.24M | 58.43M | 58.31M |
| Dividend Payout Ratio | - | - | - | 0.04% | 0.49% | 0.44% | 0.37% |
| Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 248M | 235M | 292M | 664.7M | 749.1M | 761M | 631.4M |
| Cash & Short-Term Investments | 0 | 0 | 0 | 330.9M | 326.5M | 267.5M | 225.5M |
| Cash Only | 0 | 0 | 0 | 330.9M | 326.5M | 267.5M | 225.5M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 127M | 120M | 150.6M | 23.4M | 17.9M | 248M | 145.6M |
| Days Sales Outstanding | 41.8 | 40.35 | 47.18 | 7.56 | 5.83 | 80.6 | 49.19 |
| Inventory | 101M | 102M | 118M | 122.8M | 152.1M | 171.5M | 178.6M |
| Days Inventory Outstanding | 114.13 | 115.3 | 118 | 126.4 | 149.68 | 161.38 | 161.52 |
| Other Current Assets | 0 | 0 | 200K | 109.7M | 142.4M | 74M | 81.7M |
| Total Non-Current Assets | 497M | 503M | 496M | 421.7M | 465.3M | 524.3M | 459.5M |
| Property, Plant & Equipment | 457M | 462M | 451M | 301.6M | 323.2M | 290.4M | 48.5M |
| Fixed Asset Turnover | 2.43x | 2.35x | 2.58x | 3.75x | 3.47x | 3.87x | 22.28x |
| Goodwill | 16M | 16M | 16M | 15.7M | 15.6M | 15.6M | 15.4M |
| Intangible Assets | 16M | 14M | 18M | 8.9M | 9.1M | 8.1M | 7M |
| Long-Term Investments | 0 | 0 | -11.4M | -95.5M | -140.4M | 0 | 0 |
| Other Non-Current Assets | 8M | 11M | 11M | 95.5M | 257.8M | 210.2M | 368.4M |
| Total Assets | 745M | 738M | 788M | 1.09B | 1.21B | 1.29B | 28.3M |
| Asset Turnover | 1.49x | 1.47x | 1.48x | 1.04x | 0.92x | 0.87x | 38.18x |
| Asset Growth % | - | -0.01% | 0.07% | 0.38% | 0.12% | 0.06% | -0.98% |
| Total Current Liabilities | 126M | 137M | 164M | 301M | 353.5M | 374M | 261.5M |
| Accounts Payable | 47M | 50M | 54.2M | 41.4M | 53.5M | 91M | 74.2M |
| Days Payables Outstanding | 53.11 | 56.52 | 54.2 | 42.61 | 52.65 | 85.63 | 67.1 |
| Short-Term Debt | 0 | 1M | 1M | 9.5M | 9.5M | 9.5M | 12.9M |
| Deferred Revenue (Current) | 0 | -1000K | -1000K | 0 | 1000K | 0 | 0 |
| Other Current Liabilities | 0 | 1M | 1.1M | 198M | 33.6M | 0 | 115.2M |
| Current Ratio | 1.97x | 1.72x | 1.78x | 2.21x | 2.12x | 2.03x | 2.41x |
| Quick Ratio | 1.17x | 0.97x | 1.06x | 1.80x | 1.69x | 1.58x | 1.73x |
| Cash Conversion Cycle | 102.82 | 99.13 | 110.98 | 91.35 | 102.86 | 156.35 | 143.6 |
| Total Non-Current Liabilities | 0 | 29M | 29.7M | 1.68B | 1.68B | 1.65B | 1.48B |
| Long-Term Debt | 0 | 0 | 3M | 1.6B | 1.59B | 1.57B | 1.39B |
| Capital Lease Obligations | 0 | 4M | 3M | 36.9M | 46.9M | 30.2M | 28.7M |
| Deferred Tax Liabilities | 0 | 25M | 30M | 46.1M | 57.2M | 11.9M | 62.6M |
| Other Non-Current Liabilities | 0 | 0 | 26.7M | 41.8M | 41.8M | 42.2M | 0 |
| Total Liabilities | 126M | 166M | 194M | 1.98B | 2.04B | 2.02B | 1.74B |
| Total Debt | 0 | 5M | 4M | 1.64B | 1.66B | 1.61B | 1.43B |
| Net Debt | 0 | 5M | 4M | 1.31B | 1.31B | 1.34B | 1.2B |
| Debt / Equity | - | 0.01x | 0.01x | - | - | - | - |
| Debt / EBITDA | - | 0.01x | 0.01x | 4.82x | 6.53x | 7.92x | 4.88x |
| Net Debt / EBITDA | - | 0.01x | 0.01x | 3.85x | 5.16x | 6.61x | 4.11x |
| Interest Coverage | - | - | - | 6.70x | 2.07x | 1.49x | 2.26x |
| Total Equity | 577M | 572M | 594M | -891.4M | -821.7M | -738.3M | -650.6M |
| Equity Growth % | - | -0.01% | 0.04% | -2.5% | 0.08% | 0.1% | 0.12% |
| Book Value per Share | 10.12 | 10.04 | 10.46 | -15.62 | -14.23 | -12.66 | -11.04 |
| Total Shareholders' Equity | 577M | 572M | 594M | -891.4M | -821.7M | -738.3M | -650.6M |
| Common Stock | 855M | 834M | 865M | 600K | 600K | 600K | 600K |
| Retained Earnings | 0 | 0 | 0 | -577.1M | -541.1M | -498.6M | -445.6M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -278M | -262M | -271M | -324.9M | -309.1M | -292.8M | -285.6M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Cash from Operations | 505M | 498.5M | 456M | 412.2M | 67.7M | 35.7M | 191.7M |
| Operating CF Margin % | 0.46% | 0.46% | 0.39% | 0.36% | 0.06% | 0.03% | 0.18% |
| Operating CF Growth % | - | -0.01% | -0.09% | -0.1% | -0.84% | -0.47% | 4.37% |
| Net Income | 432M | 427.6M | 415M | 223.6M | 70.4M | 78.3M | 95.4M |
| Depreciation & Amortization | 36M | 38.3M | 38M | 31.7M | 32.6M | 36.2M | 40.7M |
| Stock-Based Compensation | 12M | 12.7M | 12.8M | 18.7M | 21.5M | 26.3M | 31.6M |
| Deferred Taxes | -6M | -2.2M | -2M | -26.5M | 14.3M | -70.6M | 17.6M |
| Other Non-Cash Items | 9M | 9.4M | 24.2M | 72.3M | 8.9M | 13.2M | 30.1M |
| Working Capital Changes | 22M | 12.7M | -32M | 92.4M | -80M | -47.7M | -23.7M |
| Change in Receivables | -10M | -2.4M | -32M | 122.7M | 7M | -174.7M | 44.2M |
| Change in Inventory | 9M | 3.5M | -18M | -23.4M | -28.8M | -16.5M | -6.1M |
| Change in Payables | 32M | -3.8M | 30M | 73.3M | 7.9M | 60M | -68.9M |
| Cash from Investing | -69M | -41.9M | -39M | -24M | -26.5M | -15.8M | -9.3M |
| Capital Expenditures | -69M | -41.9M | -39M | -24M | -26.5M | -15.8M | -9.3M |
| CapEx % of Revenue | 0.06% | 0.04% | 0.03% | 0.02% | 0.02% | 0.01% | 0.01% |
| Acquisitions | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -436M | -456.6M | -417M | -48M | -48.7M | -73.4M | -226.7M |
| Debt Issued (Net) | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | -8.6M | -34.4M | -34.5M | -35M |
| Share Repurchases | - | - | - | - | - | - | - |
| Other Financing | -436M | -456.6M | -417M | -1.48B | 0 | 0 | -5.7M |
| Net Change in Cash | - | - | - | - | - | - | - |
| Free Cash Flow | 436M | 456.6M | 417M | 388.2M | 41.2M | 19.9M | 182.4M |
| FCF Margin % | 0.39% | 0.42% | 0.36% | 0.34% | 0.04% | 0.02% | 0.17% |
| FCF Growth % | - | 0.05% | -0.09% | -0.07% | -0.89% | -0.52% | 8.17% |
| FCF per Share | 7.65 | 8.01 | 7.34 | 6.80 | 0.71 | 0.34 | 3.10 |
| FCF Conversion (FCF/Net Income) | 1.17x | 1.17x | 1.10x | 1.84x | 0.96x | 0.46x | 2.01x |
| Interest Paid | 0 | 0 | 0 | 38.9M | 111M | 117.7M | 103.8M |
| Taxes Paid | 0 | 0 | 0 | 15.6M | 30.4M | 29.1M | 50.1M |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 74.87% | 74.43% | 71.15% | - | - | - | - |
| Return on Invested Capital (ROIC) | 65.25% | 63.24% | 62.81% | 45.55% | 35.61% | 22.46% | 31.39% |
| Gross Margin | 70.87% | 70.25% | 68.67% | 68.61% | 66.91% | 65.46% | 62.64% |
| Net Margin | 38.95% | 39.39% | 35.61% | 19.8% | 6.28% | 6.97% | 8.83% |
| Debt / Equity | - | 0.01x | 0.01x | - | - | - | - |
| Interest Coverage | - | - | - | 6.70x | 2.07x | 1.49x | 2.26x |
| FCF Conversion | 1.17x | 1.17x | 1.10x | 1.84x | 0.96x | 0.46x | 2.01x |
| Revenue Growth | - | -2.12% | 7.32% | -3.05% | -0.77% | 0.21% | -3.8% |
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Safety | - | - | 129.4M | 137.8M |
| Safety Growth | - | - | - | 6.49% |
| Manufacturing Facility | - | - | 12.8M | 19.9M |
| Manufacturing Facility Growth | - | - | - | 55.47% |
| Product and Service, Other | - | - | 10.3M | 14M |
| Product and Service, Other Growth | - | - | - | 35.92% |
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| UNITED STATES | 600.3M | 601.4M | 607.2M | 579.1M |
| UNITED STATES Growth | - | 0.18% | 0.96% | -4.63% |
| Non-US | 529.2M | 519.4M | 515.9M | 501.3M |
| Non-US Growth | - | -1.85% | -0.67% | -2.83% |
Embecta Corp. (EMBC) has a price-to-earnings (P/E) ratio of 7.8x. This may indicate the stock is undervalued or faces growth challenges.
Embecta Corp. (EMBC) reported $1.08B in revenue for fiscal year 2025. This represents a 3% decrease from $1.11B in 2019.
Embecta Corp. (EMBC) saw revenue decline by 3.8% over the past year.
Yes, Embecta Corp. (EMBC) is profitable, generating $94.7M in net income for fiscal year 2025 (8.8% net margin).
Yes, Embecta Corp. (EMBC) pays a dividend with a yield of 4.71%. This makes it attractive for income-focused investors.
Embecta Corp. (EMBC) generated $182.4M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.